Latus Pharma ApS: Financial statements 2021
CVR: 36974214
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
Latus Pharma ApS (CVR 36974214) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK -4,109 and a net result of DKK -4,109 compared with DKK -3,921 the year before. Equity in the 2021 report amounted to DKK 118,729. The solvency ratio was 100%.
- Revenue
- DKK 0
- Gross Profit
- DKK -4,109
- Profit/Loss
- DKK -4,109
- Equity
- DKK 118,729
- Total Assets
- DKK 118,729
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | 0 | -4 t. | -4 t. | 119 t. | - |
| 2020 | 0 | -4 t. | -4 t. | 123 t. | - |
| 2019 | 0 | -4 t. | -4 t. | 127 t. | - |
| 2018 | 0 | -4 t. | -4 t. | 131 t. | - |
| 2017 | 11 t. | -65 t. | -65 t. | 135 t. | - |
Official annual report
Find more companies like Latus Pharma ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
Latus Pharma ApS has published its annual report for 2020. Revenue came to DKK 0, and the net result was DKK -3,921.
About Latus Pharma ApS
Latus Pharma ApS is a Danish company of the type Anpartsselskab based in Køge, founded in 2015. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Jørgen Wittendorff. The company is owned by Jørgen Wittendorff. In 2025, the company reported revenue of DKK -6,991 and a net result of DKK -6,991 compared with DKK -6,897 the year before. Equity in the 2025 report amounted to DKK 82,569.